Study Evaluating the Efficacy and Safety of Remifentanil in a Rapid Sequence Induction for Fragile Subjects
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine whether, during a rapid sequence intubation by
etomidate, and succinylcholine Sellick maneuver, the administration of remifentanil at 2
different dosages (0.5 and 1.0 microgram per kg body weight), reduces potentially dangerous
reactional tachycardia.